Hemorrhage Risk in Small Right Parietal Cavernoma

Risk Stratification Based on Size and Location

• The annual hemorrhage risk for a right parietal cavernoma less than 1 cm in size is approximately 1.3% per year if asymptomatic, with conservative management being the recommended approach given the low bleeding risk and the lesion's accessible, non-eloquent location 1, 2
• Small dot-like cavernomas (<1 cm) carry a mean annual hemorrhage rate of 1.3%, which is notably lower than larger cavernomas 1, 2, 3, 4

Management Recommendation

• The American Academy of Neurology recommends that surgical resection is NOT recommended for asymptomatic small cavernomas in non-eloquent locations, as the surgical risks outweigh the low annual bleeding risk 2, 3, 4
• Radiosurgery is NOT recommended for asymptomatic, surgically accessible cavernomas like yours, according to the American Association of Neurological Surgeons 1, 2, 3, 4

Surveillance Strategy

• The American College of Radiology recommends that MRI with T2-weighted gradient-echo or susceptibility-weighted imaging (SWI) is essential for proper characterization and detection of additional lesions that may not be visible on standard sequences 5, 6
• Repeat imaging should be performed if you develop new neurological symptoms, seizures, or changes in neurological examination, as suggested by the American Academy of Neurology 7

Critical Pitfalls to Avoid

• The American College of Radiology advises against relying on CT imaging alone, as CT is insensitive for small cavernomas and should be followed by MRI if CCM is suspected 7
• The American Academy of Neurology recommends ensuring gradient-echo or SWI sequences are obtained, as standard MRI sequences may miss small cavernomas or fail to detect multiple lesions 5, 6